Biomarker analysis of blood and body fluids to support treatment decisions and disease monitoring.
Consented intake · your records travel with you · nothing moves without your sign-off
SINGLERA Genomics provides liquid biopsy testing that gathers and analyzes blood and other bodily fluids for biomarkers such as DNA, RNA, and proteins. The results can help guide treatment and monitor disease progression, with applications in minimum residual disease monitoring and early detection for patients who want to stay ahead of changes.
Prefer the source? SINGLERA Genomics's own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how SINGLERA Genomics handles billing.
We don't have confirmed insurance details for SINGLERA Genomics yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in SINGLERA's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.